Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients

BACKGROUND: Current standard therapy commonly followed for chronic Hepatitis C Virus (HCV) in Pakistan is interferon alpha plus ribavirin combination therapy (IFN α/ribavirin) and pegylated interferon plus ribavirin (PegIFN/ribavirin). PegIFN/ribavirin has increased rate of sustained virological res...

Descripción completa

Detalles Bibliográficos
Autores principales: Akram, Madiha, Idrees, Muhammad, Zafar, Shamail, Hussain, Abrar, Butt, Sadia, Afzal, Samia, Rehman, Irshad-ur, Liaqat, Ali, Saleem, Sana, Ali, Muhammad, Butt, Azeem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113307/
https://www.ncbi.nlm.nih.gov/pubmed/21575275
http://dx.doi.org/10.1186/1743-422X-8-234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113307/
https://www.ncbi.nlm.nih.gov/pubmed/21575275
http://dx.doi.org/10.1186/1743-422X-8-234

Ejemplares similares